Establishment of an Implants Registry in Germany

02

May 2019

At the beginning of April 2019, the Federal Cabinet has adopted the draft of a "Law on the Establishment of an Implant Registry in Germany and other amendments to the Fifth Book of the Social Code” (Implants Registry Establishment Law, Implantateregister-Errichtungsgesetz, EIRD).

The goal of the Registry is to improve the safety and quality of implantations for both privately and publicly health insured. By scientific assessment of the collected data, such as the lifetime of implants in the body, conclusions can be made, inter alias about the quality of the implants and the quality of the implanted devices.

Essential regulations of the EIRD include:

  • The German Institute for Medical Documentation and Information (DIMDI) will take over the central data collection as registrar. The start-up financing will be provided by the federal government, ongoing operations will be financed by fees
  • The Robert Koch Institute will establish an independent trust, which will pseudonymize all personal data
  • The telematics infrastructure will be used for transmitting the data records
  • In order to ensure the validity of the register, the registration will be obligatory for Health Care Institutions, statutory and private health insurances and all patients
  • Manufacturers will be obliged to register their products in the register's product database. In case of implanting device reporting violation or the use of implants, which were not registered in the product database, the law will provide an exclusion of payment
  • Comprehensive transparency requirements are included, such as annual reports from the Registry office and the Federal Institute for Drugs and Medical Devices (BfArM)
  • The expense incurred by the health care institutions due to the obligatory registration will be reimbursed
  • The framework conditions for the data transfer of existing registries are regulated
  • The actual beginning of the reporting obligation for the individual types of implants depends on the existence of all technical prerequisites for the receipt of the registration and will be specified by corresponding ordinance
  • It is expected that hip and knee endoprostheses and breast implants will be the first ones registered from mid-2021

The bill also contains provisions to speed up the procedure of the Federal Joint Committee (G-BA) for the evaluation of examination and treatment methods in contracted care. For this purpose, the previous timeframe for the G-BA will be shortened from three to two years.

The law does not require the approval of the Federal Council. The announcement is scheduled for the end of the current year. In addition to the law, a statutory ordinance will be worked out in order to regulate details of the Implant Registry operation.

The full details in German can be found here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

22

Mar 2022

On February 17, 2022, the Federal Joint Committee (G-BA) has decided to include the method of matrix-associated autologous chondrocyte implantation (M-ACI) on the knee joint in the case of symptomatic cartilage damage in the lists of reimbursed procedures in the hospital and ambulatory settings.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

09

Mar 2022

On February 16, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) has published the decisions which recommended the transfer to standard care for three completed projects. The projects relate to the prevention of antibiotic resistance, improvement of healthcare in socially disadvantaged areas, and misuse of control colonoscopies in Germany.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more